SENTIMENT ANALYSIS

ILMN

Illumina, Inc.
Last Updated: 2026-11-21View stock page →
SENTIMENT RATING
SENTIMENT SCORE
Bearish
44 / 100
Summary
Coverage is mixed but leans negative: Illumina disclosed voluntary Class II recalls for several diagnostic sequencing instruments over cybersecurity vulnerabilities, a story that coincided with a 1-day 4.45% drop, a 30-day 25.11% decline and a GDELT tone of 38/100. A bullish counterpoint highlights a 111.2% three-year share gain and Illumina's role in Singapore's SG-INSIGHT precision medicine effort that could support long-term revenue, but the recalls and weak recent price action dominate the near-term outlook.

Signal Breakdown

NNews
50/ 100Bearish

3 verified publisher articles from recent coverage.

TVTV
0/ 100No data

Limited TV coverage this week.

VVideos
0/ 100No data

Limited video coverage this week.

GTGDELT Tone
38/ 100Bearish

GDELT tone + context across verified sources.

What’s Driving Sentiment

Bullish Signals

  • Illumina shares have gained 111.2% over the past three years, reflecting strong historical performance.
  • Illumina's role in Singapore's SG-INSIGHT precision medicine effort could bolster long-term revenue.

Risk Factors

  • Illumina disclosed voluntary Class II recalls for several diagnostic sequencing instruments due to cybersecurity vulnerabilities.
  • The recalls coincided with a 1-day share decline of 4.45% and a 30-day decline of 25.11%.
  • Aggregate media tone is muted at 38/100, supporting a negative near-term sentiment backdrop.
Key ThemesNo themes listed

Evidence

  • 2026-11-20Source: TIINGO

    Summary: Illumina shares have gained 111.2% over the past three years; investors question whether future cash flows justify that re-rating. Illumina’s role in Singapore’s SG-INSIGHT precision medicine effort could bolster long-term revenue and supports a potentially attractive valuation.

    Bullish
  • 2026-11-20Source: TIINGO

    Summary: Illumina disclosed voluntary Class II recalls for several diagnostic sequencing instruments due to cybersecurity vulnerabilities; the news coincided with a 1-day share decline of 4.45% and a 30-day decline of 25.11%, highlighting operational-risk and data-integrity concerns that could increase regulatory scrutiny and pressure near-term demand and stock momentum.

    Bearish
  • 2026-11-20Source: TIINGO

    Summary: Head-to-head comparison evaluates MaxCyte and Illumina across profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership; notes MaxCyte's beta of 1.49 as a volatility metric versus Illumina.

    Neutral

Showing 3 of 3 verified news articles

  • Limited coverage this week.

No current verified Archive TV segments

  • Limited coverage this week.

No current verified videos

Formula & Methodology
News
Articles come from Tiingo News and GDELT. Azure OpenAI reads each headline and description and keeps items about the company.
TV
Internet Archive TV captions that name the company. Azure OpenAI drops segments that are not about the company, along with paid spots and passing mentions.
Video
Videos published on this site in the past 7 days and tagged to the company. Azure OpenAI reads the title and description, not a transcript, and its summary feeds the judge.
Holistic AI judge
A single Azure OpenAI call reads the news, television, and video evidence together and returns a 0 to 100 composite and a short rationale. There is no fixed formula: the judge weighs source quality, recency, and whether sources agree. The rating follows the composite. 72 or higher is Bullish, 50 or lower is Bearish, and anything in between is Neutral. The Signal Breakdown cards score each source on its own with the same cut-offs. They are shown for context and do not add up to the composite.
Data Source

News evidence comes from Tiingo News and from the GDELT Project (Global Knowledge Graph, via BigQuery); most listed articles come from Tiingo. TV evidence comes from the Internet Archive TV News Archive, and video evidence from recent videos on this site. Azure OpenAI filters each item for relevance and serves as the holistic AI judge that produces the composite. Portions use data from The GDELT Project under open data terms. This page is informational analysis, not investment advice. See Financial Disclaimer.